News

More Trump administration figures who met Laura Loomer’s ire are out. A look at her influence
President Donald Trump has downplayed the influence of Laura Loomer, a right-wing provocateur known for her incendiary social ...
Patients still benefit from Eisai and Biogen Alzheimer's drug after four years, study finds
Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
The Sarepta Mugging and Drug Innovation
The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.
Is the FDA Doing Enough About Food Additives?
Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and ...
KSAT11h
FDA warns about possible E. coli, Salmonella infection found in pet food sold online
The U.S. Food and Drug Administration (FDA) is issuing a warning to pet owners that certain dog food from last year may be ...
FDA commissioner predicts ‘record’ drug approvals this year
FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...
Confusion at NIH as administration halts, then releases, billions of dollars for scientific research
Billions of dollars of NIH research were stuck in limbo for hours after OMB directed the agency to halt further funding and ...
STAT16h
FDA names drug regulator Tidmarsh acting head of biologics center after Prasad’s exit
George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad.
FDA calls for illicit drug scheduling of high-dose kratom plant extract 7-OH
The Trump administration is recommending that a compound called 7-OH be scheduled as an illicit drug, Food and Drug ...
Futurism on MSN6d
The FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible Mistakes
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...